Recombinant strain expressing phospholipase D and application thereof
AssigneeJiangnan University
InventorsJinsong Shi, Zhenghong Xu, Jinsong Gong, Haijuan Hou, Xiaomei Zhang, Heng Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeJiangnan University
InventorsJinsong Shi, Zhenghong Xu, Jinsong Gong, Haijuan Hou, Xiaomei Zhang, Heng Li
Estimating the term…
The present invention provides a phospholipase D having an amino acid sequence as shown in SEQ ID NO. 1, and further provides a gene sequence encoding phospholipase D, which has a nucleotide sequence as shown in SEQ ID NO. 2. The present invention also provides a method for improving the expression level of phospholipase D by systematically engineering the expression elements. The method comprises screening and replacement of signal peptides, ribosome binding sites and promoters. The constructed recombinant plasmid is transformed into a host cell, and the recombinant strain is capable of successfully expressing phospholipase D. The phospholipase D of the present invention has a good phosphatidyl transferring ability, and can be used for synthesizing the product phosphatidylserine with lecithin and L-serine as substrates. The recombinant strain has good stability of enzyme activity and short fermentation period, which lays the foundation for large-scale industrial production.
A transgenic cell line comprising a polynucleotide that comprises the nucleotide sequence of SEQ ID NO:
A recombinant plasmid that comprises a gene encoding a phospholipase D, wherein said gene comprises SEQ ID NO:2, a nucleic acid encoding a signal peptide, wherein said nucleic acid comprises SEQ ID NO:3, a ribosome binding site that comprises SEQ ID NO:4, and a promoter that comprises SEQ ID NO:5.
A recombinant strain expressing a phospholipase D, wherein said recombinant strain is obtained by introducing a recombinant plasmid that comprises a gene encoding a phospholipase D, wherein said gene comprises SEQ ID NO:2, a nucleic acid encoding a signal peptide, wherein said nucleic acid comprises SEQ ID NO:3, a ribosome binding site that comprises SEQ ID NO:4, and a promoter that comprises SEQ ID NO:5.
Dependencies are inferred from the claim text.